In4Derm Overview

  • Status
  • Private

  • Employees
  • 7

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.45M

  • Investors
  • 3

In4Derm General Information


Developer of a biotech company intended to develop drugs for the treatment of skin diseases. The company specializes in the discovery of drugs and aims to provide an alternative to steroid creams, which are frequently prescribed for skin diseases such as psoriasis and eczema but are sometimes ineffective and can cause serious side effects, thus providing patients with safe and effective medication.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 15 Luke Place
  • Broughty Ferry
  • Dundee DD5 3BN
  • Scotland, United Kingdom

In4Derm Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

In4Derm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 27-Nov-2020 $1.45M 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 000 000 Completed Startup
1. Grant 27-Sep-2019 $61.7K Completed Startup
To view In4Derm’s complete valuation and funding history, request access »

In4Derm Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view In4Derm’s complete cap table history, request access »

In4Derm Patents

In4Derm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202016977-D0 Compounds Ceased 26-Oct-2020 0000000000

In4Derm Executive Team (3)

Name Title Board Seat Contact Info
Timothy Sparey Ph.D Co-Founder, Chief Executive Officer & Board Member
Andrew Woodland Co-Founder & Chief Scientific Officer
Mark Bell Co-Founder & Director of Chemistry and Operations
To view In4Derm’s complete executive team members history, request access »

In4Derm Board Members (2)

Name Representing Role Since
Sunil Shah O2h Ventures Board Member 000 0000
Timothy Sparey Ph.D In4Derm Co-Founder, Chief Executive Officer & Board Member 000 0000
To view In4Derm’s complete board members history, request access »

In4Derm Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

In4Derm Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
O2h Ventures Venture Capital Minority 000 0000 000000 0
Converge business plan competition Other 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0
To view In4Derm’s complete investors history, request access »